» Articles » PMID: 34386656

Association of Admission, Nadir, and Terminal Donor Creatinine With Kidney Transplantation Outcomes

Overview
Journal Kidney Int Rep
Publisher Elsevier
Specialty Nephrology
Date 2021 Aug 13
PMID 34386656
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: When assessing deceased kidney donors, a key factor in organ acceptance and allocation is donor kidney function. It is unclear whether terminal, admission, or the highest of terminal and admission donor estimated glomerular filtration rate (eGFR) most predicts recipient outcomes.

Methods: We examined which measurement best predicts outcomes. Using data from the Australia and New Zealand Organ Donation and Dialysis and Transplant Registries, we included adult recipients of deceased donor kidney-only transplants over 2003 to 2019. We compared the 3 different exposure variables of admission, terminal, or highest eGFR. We created logistic regression models for delayed graft function (DGF), multilinear regression models for 6- and 12-month eGFR, and Cox proportional hazards models for graft loss, death censored graft failure and patient death.

Results: A total of 8971 transplant recipients were included. There was strong evidence of an association between terminal, admission, and highest donor eGFR and DGF and recipient eGFR at 6 and 12 months. The eGFR was a strong predictor of graft and death censored graft failure, but not patient death. Terminal was a better predictor than admission and highest eGFR particularly for more contemporaneous outcomes.

Conclusion: In assessing kidney donors, terminal eGFR were marginally better than admission and highest at predicting outcomes. Terminal eGFR should be used in risk equations to predict hard clinical endpoints.

Citing Articles

Protein biomarkers in assessing kidney quality before transplantation‑current status and future perspectives (Review).

Baryla M, Skrzycki M, Danielewicz R, Kosieradzki M, Struga M Int J Mol Med. 2024; 54(6).

PMID: 39370783 PMC: 11448562. DOI: 10.3892/ijmm.2024.5431.


"Long-term effects of center volume on transplant outcomes in adult kidney transplant recipients".

Azhar A, Defor E, Bandyopadhyay D, Kamal L, Tanriover B, Gupta G PLoS One. 2024; 19(6):e0301425.

PMID: 38843258 PMC: 11156332. DOI: 10.1371/journal.pone.0301425.


Deceased-Donor Kidneys: Is Past Performance an Indicator of Future Transplant Success?.

Raghavan D, Tomacruz I, Hall I Kidney Int Rep. 2021; 6(8):2025-2027.

PMID: 34386650 PMC: 8344110. DOI: 10.1016/j.ekir.2021.06.009.

References
1.
Meier-Kriesche H, Ojo A, Port F, Arndorfer J, Cibrik D, Kaplan B . Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol. 2001; 12(6):1293-1296. DOI: 10.1681/ASN.V1261293. View

2.
Chiles M, Ali Husain S, Skillen W, Lee S, Carpenter D, Pastan S . Predictive Value of Using Initial Versus Terminal Deceased Donor Creatinine to Calculate the Kidney Donor Risk Index. Am J Kidney Dis. 2017; 70(1):153-154. DOI: 10.1053/j.ajkd.2017.02.373. View

3.
Zheng Y, Chen C, Yuan X, Wang C . Impact of acute kidney injury in donors on renal graft survival: a systematic review and Meta-Analysis. Ren Fail. 2018; 40(1):649-656. PMC: 6225519. DOI: 10.1080/0886022X.2018.1535982. View

4.
Hoste E, Bagshaw S, Bellomo R, Cely C, Colman R, Cruz D . Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015; 41(8):1411-23. DOI: 10.1007/s00134-015-3934-7. View

5.
Rao P, Schaubel D, Guidinger M, Andreoni K, Wolfe R, Merion R . A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation. 2009; 88(2):231-6. DOI: 10.1097/TP.0b013e3181ac620b. View